<![CDATA[Younger Age at Glomerular Disease Diagnosis Linked to Greater Lifetime Risk Despite Similar Progression Rates]]> / HCP Live
hcplive -
Saturday, November 8, 2025, 8:21 pm / permalink 15810 / 3 stories in 4 months
Pfizer poised to buy Metsera in $10 bn deal after bidding war / Medical Express
medicalxpress - Pfizer was poised to seal a takeover of Metsera on Saturday after its improved offer won over the biotechnology startup's board and Danish challenger Novo Nordisk called a halt to a back-and-forth bidding war.
#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #pfizer #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment
Saturday, November 8, 2025, 3:21 pm / permalink 15805 / 2 stories in 4 months
Intensive blood pressure lowering could benefit almost all adults with hypertensive chronic kidney disease / Medical Express
medicalxpress - An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney disease (CKD) would have benefits that outweigh the harm from a systolic blood pressure target of
Saturday, November 8, 2025, 2:22 pm / permalink 15802 / 2 stories in 4 months
#AHA25: Amgen’s cholesterol drug cuts first-time cardiovascular events by a quarter / Endpoints
Elizabeth Cairns / endpoints - Amgen on Saturday said its cholesterol-lowering drug Repatha cut cardiovascular events by 25% when added on top of standard therapy in high-risk patients who have never had a heart attack or stroke. Repatha is already ...
#healthcare #pharmaceuticals #publichealth
Saturday, November 8, 2025, 9:21 am / permalink 15793 / 13 stories in 4 months
FDA approves J&J’s Darzalex for smoldering multiple myeloma / Endpoints
Lei Lei Wu / endpoints - The FDA on Thursday approved Johnson & Johnson’s Darzalex injection for high-risk smoldering multiple myeloma, a condition in which people have abnormal cells that could turn into myeloma but don’t have ...
#healthcare #pharmaceuticals #publichealth
Saturday, November 8, 2025, 12:21 am / permalink 15786 / 3 stories in 4 months
Patient in Intellia CRISPR trial dies after being hospitalized with liver injury / Endpoints
Ryan Cross / endpoints - A man in his early 80s who was recently hospitalized with liver injury, a few weeks after receiving an experimental gene editing therapy, died on Wednesday ...
#healthcare #pharmaceuticals #publichealth
Saturday, November 8, 2025, 12:21 am / permalink 15784 / 2 stories in 4 months
CMS unveils new Medicaid drug payment model / Endpoints
Max Bayer / endpoints - CMS plans to launch a new drug payment model for state Medicaid programs, the first of potentially multiple pricing models under President Donald Trump's "most favored nation" push that the pharma industry has been closely ...
#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy
Saturday, November 8, 2025, 12:21 am / permalink 15785 / 3 stories in 4 months
What Trump’s New Drug Pricing Deal Means for People With Obesity / NYT
Rebecca Robbins, Dani Blum and Margot Sanger-Katz / nytimes - The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.
#trumpadministration #obesity #healthcare #pharmaceuticals #drugpricing #elililly #novonordisk #weightloss #publichealth #governmentpolicy
Friday, November 7, 2025, 11:57 pm / permalink 15780 / 6 stories in 4 months